Literature DB >> 1505086

Magnetic resonance imaging of the parotid gland using the STIR sequence.

R Chaudhuri1, J B Bingham, J E Crossman, M J Gleeson.   

Abstract

The object of this study was to determine the efficiency of the short tau inversion recovery (STIR) sequence in the assessment of salivary disease. Sixteen patients with tumours either in or adjacent to the parotid gland were imaged using a 1.5T Philips Gyroscan, with a standard head coil. T1-weighted spin-echo and STIR sequences were obtained in multiple planes and assessed independently by each of the authors. Positive fine needle aspiration cytology or histological proof of the nature of the imaged lesions was obtained for every patient. T1-weighted spin-echo images were most useful for visualizing anatomical structures and for identification of the facial nerve. All lesions were visible with T1-weighted images but were very much more conspicuous in the STIR sequences, for which a minimal lesion resolution of 6 mm was achieved. No contrast enhancement was required. It was not possible to determine the pathological nature of the lesion by scan appearance only. Our conclusion is that a combination of T1-weighted spin-echo and STIR sequences in the axial and coronal planes is the preferred protocol for salivary gland imaging.

Entities:  

Mesh:

Year:  1992        PMID: 1505086     DOI: 10.1111/j.1365-2273.1992.tb01829.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  2 in total

1.  Incidental findings during head and neck MRI screening in 1717 patients with temporomandibular disorders.

Authors:  Takashi Kamio; Takashi Yakushiji; Takashi Takaki; Takahiko Shibahara; Kenichi Imoto; Mamoru Wakoh
Journal:  Oral Radiol       Date:  2018-04-03       Impact factor: 1.852

2.  Warthin tumor of the parotid gland: diagnostic value of MR imaging with histopathologic correlation.

Authors:  Mitsuaki Ikeda; Ken Motoori; Toyoyuki Hanazawa; Yuichiro Nagai; Seiji Yamamoto; Takuya Ueda; Hiroyuki Funatsu; Hisao Ito
Journal:  AJNR Am J Neuroradiol       Date:  2004-08       Impact factor: 3.825

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.